Live Breaking News & Updates on Polaris 02 Trial

Stay updated with breaking news from Polaris 02 trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approval Insights: Toripalimab in Recurrent/Metastatic Nasopharyngeal Carcinoma

Drs Hanna and Kandula discuss the significance of the FDA approval of toripalimab in nasopharyngeal carcinoma; pivotal data from the JUPITER-02 and POLARIS-02 trials; and how this regulatory decision increases the importance of multidisciplinary collaboration. ....

Dana Farber Cancer Institute , United States , Shravan Kandula , Ashling Wahner , Glennj Hanna , Harvard Medical School , Cancer Therapeutic Innovation Early Drug Development Program , Live On Air , Cancer Therapeutic Innovation , Early Drug Development Program , Rare Head , Neck Cancers , Adventhealth Medical Group Radiation Oncology , Central Florida , Drs Hanna , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music , Fda Approval Of Toripalimab In Nasopharyngeal Carcinoma , Jupiter 02 Trial , Polaris 02 Trial ,